Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Debora Keunyoung Kim"'
Autor:
Yung-Jue Bang, Mark J. O'Connor, Alan Lau, Jeff Brown, Do-Youn Oh, Tae-Yong Kim, Jin Won Kim, Kyung-Hun Lee, Hee-Jun Kim, Yaewon Yang, Debora Keunyoung Kim, Miso Lee, Seongyeong Kim, Hyemin Jang, Seock-Ah Im, Ahrum Min
Conflict of Interest Form
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::146122d7bd6bf8c8ee659602acf859b1
https://doi.org/10.1158/1535-7163.22507636
https://doi.org/10.1158/1535-7163.22507636
Autor:
Seock-Ah Im, Mark J. O'Connor, Paul Elvin, Yaewon Yang, Koung Jin Suh, Debora Keunyoung Kim, Kyung-Hun Lee, Seongyeong Kim, Hyemin Jang, Ahrum Min
TOPORS expression determined the combined effects of AZD3514 and olaparib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::293c988f615ffed70813df8ab2d76a9f
https://doi.org/10.1158/1535-7163.22505781
https://doi.org/10.1158/1535-7163.22505781
Autor:
Yung-Jue Bang, Mark J. O'Connor, Alan Lau, Jeff Brown, Do-Youn Oh, Tae-Yong Kim, Jin Won Kim, Kyung-Hun Lee, Hee-Jun Kim, Yaewon Yang, Debora Keunyoung Kim, Miso Lee, Seongyeong Kim, Hyemin Jang, Seock-Ah Im, Ahrum Min
Effects of AZD6738 on DNA damage repair capacity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::987d5ca31ab217d4715416253db52916
https://doi.org/10.1158/1535-7163.22507627.v1
https://doi.org/10.1158/1535-7163.22507627.v1
Autor:
Yung-Jue Bang, Mark J. O'Connor, Alan Lau, Jeff Brown, Do-Youn Oh, Tae-Yong Kim, Jin Won Kim, Kyung-Hun Lee, Hee-Jun Kim, Yaewon Yang, Debora Keunyoung Kim, Miso Lee, Seongyeong Kim, Hyemin Jang, Seock-Ah Im, Ahrum Min
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::635269102bd8dc977030a52866b8ed78
https://doi.org/10.1158/1535-7163.22507633
https://doi.org/10.1158/1535-7163.22507633
Autor:
Seock-Ah Im, Mark J. O'Connor, Paul Elvin, Yaewon Yang, Koung Jin Suh, Debora Keunyoung Kim, Kyung-Hun Lee, Seongyeong Kim, Hyemin Jang, Ahrum Min
The androgen receptor (AR) is expressed in 60%–70% of breast cancers regardless of estrogen receptor status, and has been proposed as a therapeutic target in breast cancers that retain AR. In this study, the authors aimed to investigate a new treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd711b77f6231e737e77ca45c8eaefb0
https://doi.org/10.1158/1535-7163.c.6538182.v1
https://doi.org/10.1158/1535-7163.c.6538182.v1
Autor:
Yung-Jue Bang, Mark J. O'Connor, Alan Lau, Jeff Brown, Do-Youn Oh, Tae-Yong Kim, Jin Won Kim, Kyung-Hun Lee, Hee-Jun Kim, Yaewon Yang, Debora Keunyoung Kim, Miso Lee, Seongyeong Kim, Hyemin Jang, Seock-Ah Im, Ahrum Min
Anti-proliferative effects of AZD6738 on gastric cancer cell lines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42a294fb18544953c778147123aafaa4
https://doi.org/10.1158/1535-7163.22507600.v1
https://doi.org/10.1158/1535-7163.22507600.v1
Autor:
Yung-Jue Bang, Mark J. O'Connor, Alan Lau, Jeff Brown, Do-Youn Oh, Tae-Yong Kim, Jin Won Kim, Kyung-Hun Lee, Hee-Jun Kim, Yaewon Yang, Debora Keunyoung Kim, Miso Lee, Seongyeong Kim, Hyemin Jang, Seock-Ah Im, Ahrum Min
Ataxia telangiectasia and Rad3-related (ATR) can be considered an attractive target for cancer treatment due to its deleterious effect on cancer cells harboring a homologous recombination defect. The aim of this study was to investigate the potential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f171db9087deba651e29c28f739d91a
https://doi.org/10.1158/1535-7163.c.6538738.v1
https://doi.org/10.1158/1535-7163.c.6538738.v1
Autor:
Paul Elvin, Hyemin Jang, Yaewon Yang, Mark J. O'Connor, Koung Jin Suh, Seock Ah Im, Ahrum Min, Kyung Hun Lee, Debora Keunyoung Kim, Seongyeong Kim
Publikováno v:
Molecular Cancer Therapeutics. 17:2507-2518
The androgen receptor (AR) is expressed in 60%–70% of breast cancers regardless of estrogen receptor status, and has been proposed as a therapeutic target in breast cancers that retain AR. In this study, the authors aimed to investigate a new treat
Autor:
Alan Lau, Ahrum Min, Kyung Hun Lee, Miso Lee, Do Youn Oh, Mark J. O'Connor, Seongyeong Kim, Debora Keunyoung Kim, Tae Yong Kim, Jin Won Kim, Hee Jun Kim, Hyemin Jang, Jeffrey L. Brown, Yaewon Yang, Yung-Jue Bang, Seock-Ah Im
Publikováno v:
Molecular Cancer Therapeutics. 16:566-577
Ataxia telangiectasia and Rad3-related (ATR) can be considered an attractive target for cancer treatment due to its deleterious effect on cancer cells harboring a homologous recombination defect. The aim of this study was to investigate the potential
Autor:
Sae-Won Han, Tae-You Kim, Mark J. O'Connor, Do Youn Oh, Seock-Ah Im, Yung-Jue Bang, Debora Keunyoung Kim, Tae Yong Kim, Sang Hyun Song, Hee Jun Kim, Ahrum Min, Kyung Hun Lee
Publikováno v:
Breast Cancer Research : BCR
Introduction Olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, has been found to have therapeutic potential for treating cancers associated with impaired DNA repair capabilities, particularly those with deficiencies in the homologous recombi